基于利益相关者理论探究公立医院药品供应链风险评估指标体系的构建

Research on the Construction of Risk Assessment Index System of Drug Supply Chain in Public Hospitals Based on Stakeholder Theory

目的:构建公立医院药品供应链风险评估指标体系,对当前该供应链存在的风险进行科学的识别和评价,进而为医院经营管理提供科学依据,促进医院高质量发展。方法:根据利益相关者和物理-事理-人理(WSR)理论,初步建立公立医院药品供应链风险评估指标体系,运用德尔菲法,对各级指标进行了增删与修改。结果:经过两轮专家咨询,构建了包含6个一级指标和40个二级指标的风险评估指标体系,专家熟悉系数为0.76,判断系数为0.83,权威系数为0.795,两轮咨询的卡方检验P值均小于0.05,具有统计学意义。结论:在该指标体系中,从利益相关者视角看,政府和药品制造方风险较大;从物理-事理-人理维度上看,风险主要集中在事理层面。

Objective: To construct the risk evaluation index system of drug supply chain in public hospitals,scientifically identify and evaluate the risks in the current drug supply chain in public hospitals, so as to provide scientific basis for hospital management and promote the high-quality development of the hospitals. Methods:According to the stakeholder and WSR theory, the risk assessment index system of drug supply chain in public hospitals was preliminarily established, and the indexes at all levels were added, deleted and modified by Delphi method. Results: After two rounds of expert consultation, a risk assessment index system, including 6 primary indexes and 40 secondary indexes, was constructed. The expert familiarity coefficient was 0.76, the judgment coefficient was 0.83, and the authority coefficient was 0.795. The P values of chi square test of the two rounds of consultation were both less than 0.05, which was statistically significant. Conclusion: In this index system,the government and drug manufacturers are more risky from the perspective of stakeholders;from the physicalfactual-human dimensions, the risks are mainly concentrated in the factual dimension.